Safety of IV Iron Products and Review of Ferric Derisomaltose in CKD Patients - PWR 12.02.2022
powernephron
Published on Dec 13, 2022
Dr. Karen Shalansky, Dr. Kevin Kwok, Dr. Hilary Wu present, "Safety of IV Iron Products and Review of Ferric Derisomaltose in CKD Patients."
Category
- Your Subscription
powernephron -
Share Video
Add to
Please Sign In or Create Account to use this feature!
Flag Video
Please Sign In or Create Account to use this feature!
Rate video
Please Sign In or Create Account to use this feature!
Rate video
Please Sign In or Create Account to use this feature!
Up next
Autoplay
Autoplay
Recommended
-
35:15
Management of Hyperkalemia in Patients With Hemodialysis-Dependent CKD
54 views 1366 days ago -
25:08
HIF Stabilizer Trials in CKD/HD Patients – What Do the Data Really Show?
52 views 1161 days ago -
24:13
Gestational and Chronic Hypertension - CRASH! Medical Review Series
38 views 909 days ago -
47:17
Renin angiotensin system blockade in COVID-19: A tumultuous year in review
45 views 1342 days ago -
52:24
New Insights into the Diagnosis and Treatment of AKI in Patients with ADHF
49 views 1342 days ago -
30:35
Christopher Blosser, MD - Cancer in Patients with Kidney Disease
46 views 1164 days ago